The quantity and distribution of adipose tissue are markers of morbidity risk. The third trimester of human development is a period of rapid adipose tissue deposition. Preterm infants may be at risk of altered adiposity. We measured anthropometric indices and quantified total, subcutaneous, and intraabdominal adipose tissue volumes using whole-body magnetic resonance adipose tissue imaging in 38 infants born at Ͻ32 wk gestational age, when they reached term, and 29 term-born infants. The preterm infants at term were significantly lighter and shorter than the term-born infants, but there was no significant difference in head circumference SD score or total adiposity. The preterm infants had a highly significant decrease in subcutaneous adipose tissue and significantly increased intraabdominal adipose tissue. Accelerated postnatal weight gain was accompanied by increased total and subcutaneous adiposity. Illness severity was the principal determinant of increased intraabdominal adiposity. Our data provide evidence of causal pathways linking accelerated postnatal growth with increased total and subcutaneous adiposity, and illness severity with altered adipose tissue partitioning. We suggest that these observations may in part explain the associations between small size at birth and later disease. Preterm infants may be at risk in later life of metabolic complications through increased and aberrant adiposity. The distribution, as well as the quantity of AT, is a marker of morbidity risk. Adipose tissue is metabolically active, and differences in adiposity-associated morbidity are in keeping with the known depot-specific differences in the expression of genes coding for adipocyte proteins (1) . In adults, subcutaneous adiposity is primarily related to circulating leptin and generalized obesity, whereas intraabdominal (visceral) adiposity is associated with insulin resistance, even in lean individuals, and with dyslipidemia (2) . Such associations are increasingly reported in children, but the age at which abnormal patterns of adiposity are established is not known (3, 4) . The third trimester of pregnancy is a period of rapid AT deposition. Infants born extremely preterm are profoundly deficient in AT. Subsequently, their postnatal course is often marked by prolonged nutritional compromise, chronic illness, and poor growth. These are plausible determinants of both reduced and aberrant AT deposition.
Previous in vivo body composition studies in infants have been indirect and therefore unable to quantify specific AT depots. We have developed the application of whole-body magnetic resonance (MR) AT imaging to newborn infants (5) and have published data on adipose distribution in a separate cohort of term infants (6) . The technique is noninvasive and radiation free and enables direct quantification of individual AT compartments.
The aim of this study was to address the null hypothesis that total adiposity and AT distribution in extremely preterm infants, upon reaching the age of term-equivalent, does not differ from term-born newborns. Secondary aims were to examine growth performance in the preterm infants at age termequivalent and the effects of size at birth, postnatal growth, postnatal diet, and illness severity upon total adiposity and AT distribution.
METHODS
Infants were recruited from the Hammersmith and Queen Charlotte's Hospital neonatal unit and postnatal wards between December 2002 and December 2003. The study was approved by the local research ethics committee and written parental consent was obtained. Preterm infants born at Ͻ32 wk gestation were studied at age term-equivalent. Healthy, appropriately grown term infants were studied within 6 d of birth.
Magnetic resonance imaging and image analysis. Infants underwent whole-body magnetic resonance imaging as previously described by our group (5) . This was performed in natural sleep with the infant positioned supine. Heart rate and oxygen saturation are monitored continuously using pulse oximetry. A neonatologist was present throughout the procedure.
MR images were acquired on a Phillips 1.5 Tesla system using a rapid T1-weighted spin-echo sequence (repetition time of 600 ms, echo time of 16 ms). The serial isocenter technique was used, in which the infant was moved through the magnet on a mobile platform for full-body imaging. Images were obtained with a slice and interslice thickness of 5 mm. There is little effect on the overall quantification of ATV if gaps between slices do not exceed one slice thickness (7) . Images ( Fig. 1) were analyzed by a single observer (S.U.) using a commercially available software program (SliceOMatic, Version 4.2, Tomovision, Montreal, Canada) that has been widely used in body composition studies. Initially a filter was used to distinguish between different graylevel regions on each slice. The observer then used an interactive slice editor program to verify and, where necessary, edit the segmentation.
Classification of AT compartments. The classification of AT in previously published imaging studies in adults and children is inconsistent and the definition of intraabdominal or visceral AT has often not been clear (8) . Methods to quantify AT have also varied, with some studies using a singleslice technique and others restricting imaging to the abdomen. There is further controversy over what constitutes the so-called "deep subcutaneous abdominal" depot. This distinct compartment is clearly separated from subcutaneous AT by a fascial plane. It is morphologically and metabolically different from subcutaneous AT and behaves like intraabdominal AT in that it is a risk factor for insulin resistance (9, 10) . For the purposes of this study, we defined AT as either subcutaneous (SCAT) or internal (IAT). We further classified IAT as either intraabdominal (IAIAT) or nonabdominal (NAIAT). We defined the intraabdominal compartment as IAT contained in the slices ranging from the top of the liver to the heads of the femurs inside the fascial plane referred to above. NAIAT was predominantly located in the head and neck.
Calculation of AT area, volume, and mass. Tissue area (cm 2 ) for each slice was calculated as the sum of the pixels multiplied by pixel area. Tissue volume (cm 3 ) for each slice was calculated by multiplying the tissue area by the sum of the slice thickness (0.5 cm) and the interslice distance (0.5 cm). ATV was converted to mass based on a density of AT of 0.9g/cm 3 (11) . Therefore, ATV (liters) ϫ 0.9 ϭ AT mass (kg).
We expressed total AT mass as a percentage of infant weight (%ATM) and individual compartments as percentage of total ATV (%SCATV, %IATV, %IAIATV, %NAIATV). Thus, total ATV ϭ (SCATV ϩ IATV), where IATV ϭ (IAIATV ϩ NAIATV).
We determined intraobserver variability separately for the preterm and the term infants. The coefficient of variation in the preterm infants was 2.8% for TAT, 0.77% for SCAT, and 10.56% for IAIAT and, for the term infants, 1.33%, 0.39%, and 1.45%, respectively. This compares favorably with our previous work and that reported in the adult literature where the coefficient of variation for SCAT is in the range of 2-5% and that for IAIAT from 9% to 18% (9, 12, 13) .
Sample size. We aimed to study a minimum of 27 infants in each group within the 1-y study period as, based upon our previous data, this would allow us to detect a 3% difference in total adiposity (80% power, 5% significance) (6) .
Anthropometry. Weight and OFC at birth were documented and, at the time of imaging, weight, OFC, and length were measured by a single observer (S.U.). Scales used were accurate to 0.2 g (Marsden Professional Baby Scale, London, UK), length was measured with a Rollametre (Raven Equipment Ltd., Dunmow, Essex, UK), and OFC with a nondistensible tape measure (Child Growth Foundation, London, UK).
Nutritional data. The type of intravenous nutrition (10% dextrose or parenteral nutrition) and enteral feed (donor-banked expressed breast milk, maternal expressed breast milk, preterm formula, term formula) the preterm babies received was noted for every day from birth to the day before imaging. The number of days of breast milk received (taking into account that babies might be on more than one type of nutrition on any given day) was expressed as a percentage of the total number of days from birth to the day before imaging (% breast milk).
Illness severity. We documented the number of days of level 1 and 2 intensive care received using the British Association of Perinatal Medicine criteria (2001). Data required to assign level of care were captured daily and defined the clinical status of the infant. Level 1 is the most intensive, and level 4 is normal care of a healthy newborn baby. We expressed days of level 1 and 2 intensive care as a percentage of the number of days from birth to the day before imaging (%level 1&2 IC).
Postnatal growth. We expressed weight, length, and OFC as SDS adjusted for age and gender. In the preterm group, rate of growth between birth and age term-equivalent was expressed as weight SDS gain (weight SDSG) and OFC SDSG (Child Growth Foundation). This is the difference in SDS adjusted for sex and reference correlations between measurements at two time points (14) .
Statistical analysis. Data were analyzed using SPSS Version 12 (SPSS Inc., Chicago, IL) and Stata Release 8 (StataCorp, College Station, TX). The preterm and term data were compared using the independent samples t test. Equal variances were not assumed because of the greater variability in the preterm data. Data obtained at the time of imaging was adjusted to the overall mean age at imaging using separate robust regression lines for each group. Unless otherwise stated, data are presented as mean (SD). Linear and multiple regression analyses were used to examine the influence of GA at birth, percentage breast milk received, %level 1&2 IC, and weight and head circumference SDSG on %ATM, %SCATV, and %IAIATV. When analyzing the effect of SDSG, the SDS at birth was taken into account to allow for regression to the mean.
RESULTS
We studied 67 infants (Table 1) . Thirty-eight were born preterm (14 male, 24 female) and 29 at term (12 male, 17 female). At birth, mean (SD) GA, weight, and head circumference were as follows: preterm, 28.8 wk (2.1 wk) ; term, 39.9 wk (1.4 wk) ; preterm, 1.19 kg (0.37 kg); term, 3.47 kg (0.29 Thirty-four of the preterm infants had received antenatal steroids. None of the infants had received postnatal steroid therapy. The preterm infants received breast milk ranging from 9% to 96% of days between birth and term (median, 89%) and required level 1 & 2 IC for 0 to 88% of days (median, 29%).
In the preterm group, median weight SDSG to age termequivalent was Ϫ1.24, with a range of Ϫ3.57 to 1.86. In contrast, median OFC SDSG was 0.34, with a range of Ϫ4.47 to 3.53. Mean (SD) weight, length, and OFC of the preterm babies at term-equivalent were 2.68 (0.26) kg, 47.06 (2.93) cm, and 33.79 (1.8) cm, respectively. Weight and length SDS of the preterm babies at age term-equivalent were significantly less than the term born babies but there was no significant difference in OFC SDS (Table 1) .
Actual postmenstrual age at imaging of the preterm and term infants differed [preterm, 38.6 wk (1.7 wk); term, 40.2 wk (1.5 wk); p Ͻ 0.001]. Absolute ATV were therefore compared after adjusting for age at imaging (Table 1) . Absolute total and subcutaneous ATV were significantly lower in the preterm infants, but there was a significant increase in absolute IA-IATV [mean difference, 0.005 L; 95% confidence interval (CI), Ϫ0.009 to Ϫ0.001; p ϭ 0.01].
Although significantly smaller than term infants, %ATM in the preterm infants at term was not significantly different from the term-born infants (Table 2 ). This masked a highly significant difference in the distribution of AT. Subcutaneous AT (%SCATV) was reduced in the preterm babies (preterm, 88.5%; term 91.9%; 95% CI for difference, 2.36 to 4.42; p Ͻ 0.001) and intraabdominal IAT (%IAIATV) was increased (preterm, 4.62%; term, 3.11%; 95% CI for difference, Ϫ1.92 to Ϫ1.10; p Ͻ 0.001).
In the preterm infants, linear regression analysis demonstrated the adverse impact of increasing %level 1&2 IC on %SCATV (r ϭ Ϫ0.58, p Ͻ 0.001), weight SDSG (r ϭ Ϫ0.50, p ϭ 0.002) and OFC SDSG (r ϭ Ϫ0.33, p ϭ 0.042).
Weight SDSG, but not OFC SDSG, showed a significant positive correlation with %ATM (r ϭ 0.40, p ϭ 0.014). Weight SDSG was also significantly correlated with %SCATV (r ϭ 0.404, p ϭ 0.012).
%SCATV increased with increasing GA at birth (r ϭ 0.39, p ϭ 0.016). There was a negative correlation between birth weight SDS and birth OFC SDS and %IAIATV, although this failed to reach significance (r ϭ Ϫ0.31, p ϭ 0.056; r ϭ Ϫ0.29, p ϭ 0.074, respectively).
The negative impact of increased %level 1&2 IC on %SCATV was confirmed in a multiple regression analysis (Table 3) , allowing for GA at birth, birth weight SDS, and weight SDSG (adjusted R 2 33.7%, B ϭ Ϫ0.076, SE ϭ 0.03, p ϭ 0.017). Conversely, a multiple regression model also incorporating GA at birth, birth weight SDS, and weight SDSG showed increased %IAIATV with increasing %level 1&2 IC (adjusted R 2 20.7%, B ϭ 0.033, SE ϭ 0.012, p ϭ 0.009). We found no evidence of any effect of breast milk, nor of gender, on AT outcomes.
DISCUSSION
We have made the novel observation that AT distribution is altered in the preterm infant at term with significantly increased intraabdominal adiposity. The mean excess IAIAT in the preterm infants was 5 cm 3 when expressed as an absolute volume and 1.51% when expressed as a percentage of total ATV. Is this likely to be of clinical relevance? To our knowledge, there have been no studies in infants and few studies in adults that have measured whole-body AT and expressed IAIAT as a percentage of total ATV. Thomas et al. (7) , in a study of 67 women with a range of body mass indices, found percentage of IAIAT varied from a mean of 5.7% in women with a low body mass index to 8.7% in those considered obese. In children and adults, increased intraabdominal adiposity is a recognized marker for insulin resistance, dyslipidemia, and other components of the metabolic syndrome. Weight loss confers improve- 213 ment in insulin resistance, but it is the concomitant decrease in IAIAT that appears to be important (15) . IAIAT accounts for about 18% of total body AT in aging rats, and surgical removal results in reversal of insulin resistance and improved glucose tolerance (16) . In otherwise healthy adults, excessive intraabdominal adiposity tends to accompany generalized obesity but in certain pathologic states, such as human immunodeficiency virus-associated lipodystrophy and other acquired and congenital lipodystrophies, intraabdominal adiposity occurs without an increase in subcutaneous or total adiposity (17) (18) (19) . In either situation, a decrease in IAIAT is a therapeutic goal and confers clinical benefit, suggesting that an altered distribution, with a relative increase in IAIAT, carries the same risk as an absolute increase in IAIAT (20) . The preterm infants in our study had both a relative (expressed as a percentage of total ATV) and an absolute increase (despite their significantly smaller body size) in IAIAT, suggesting that this is a real effect that is likely to be clinically relevant. What might determine this increase in intraabdominal adiposity? Excessive glucocorticoid exposure, whether exogenous as in steroid treated subjects, or endogenous as in Cushing's disease, results in IAIAT accumulation. Stress-associated glucocorticoid release is thought to be one of the mechanisms underlying the metabolic syndrome. We have observed elevated glucocorticoid levels in preterm infants in intensive care (unpublished data). In the present study, we have shown a strong association between disease severity and the quantity of IAIAT. We have also shown that antenatal compromise, as represented by low birth weight SDS and birth OFC SDS, was negatively correlated with %IAIATV, although this did not reach statistical significance. These observations suggest that exposure to an adverse environment either in utero, or after birth, increases intraabdominal adiposity. Neonatal steroid treatment has been shown to decrease insulin sensitivity in small-for-gestational-age infants (21) . None of the infants in our study received postnatal steroid therapy, but chronic or excessive endogenous glucocorticoid exposure might underlie the increase in intraabdominal adiposity, as well as the suppression in linear growth.
Nutritional support after preterm birth has largely been directed toward mimicking intrauterine growth and after intrauterine growth restriction, in achieving catch-up through accelerated growth because poor growth, particularly poor head growth, is associated with adverse neurodevelopmental outcome. However, concern has recently been raised about the promotion of rapid weight gain in infancy. Singhal et al. (22) , in a post hoc analysis of infants recruited in the early 1980s into a series of randomized controlled trials of infant feeding, showed that markers of insulin resistance were greater in a group of preterm infants fed a nutrient-enriched formula in comparison with preterm babies fed a nutrient-poor intake in whom there had been no rapid postnatal growth. These authors conclude that a period of relative nutrient deprivation in the postnatal period may be advantageous. Our data suggest an alternative hypothesis explaining the association between preterm birth and insulin resistance, namely illness severity, shown by us to be the principal determinant of increased intraabdominal adiposity.
Poor growth frequently accompanies extremely preterm birth and clinical management generally aims to promote nutritional intake. The preterm babies in this study were lighter and shorter at term-equivalent than the term-born infants. Head growth, however, appeared to have been maintained and, despite being smaller, percentage adiposity in the preterm group was similar to that of the term-born babies. This suggests that the poor linear and somatic growth in the preterm group was unlikely to have been due to poor nutrition.
Rapid postnatal growth has been associated with obesity in childhood and there has been considerable debate about the protective effect of breast milk (23) (24) (25) . Dewey (26) , in a review of published evidence, concluded that although a protective effect of breast milk remains plausible, the magnitude of any such effect is likely to be small. Clinical practice in our unit is to use maternal or banked expressed breast milk in the first few weeks after birth. We found no evidence of a relationship between quantity of breast milk received and total, intraabdominal, or subcutaneous AT.
Epidemiologic research indicates that small birth size and accelerated postnatal growth are risk factors for obesity in childhood and adult life but causal pathways are unknown (27) and direct observational data are lacking. We found a significant correlation between accelerated postnatal growth, expressed as weight SDSG, and total adiposity (%ATM). This suggests that by increasing adiposity, accelerated growth may increase susceptibility to other late-onset superimposed determinants of obesity. We regret that we do not have data on linear growth, as the finding of a similar relationship between length SDSG and adiposity would strengthen this conclusion.
Associations have also been described between small size at birth and later-life risks of hypertension, dyslipidemia, and insulin resistance (28) . Preterm birth may be associated with risks that are distinct from those of poor intrauterine growth, although these are likely to overlap. We have previously shown that antenatal growth restriction is associated with a marked 214 reduction in subcutaneous, but relative conservation of intraabdominal AT (6) . Failure to distinguish between intrauterine growth restriction and preterm birth may, at least in part, explain the heterogeneity in clinical phenotype in childhood and adult life in infants who were small at birth. Our data suggest possible explanations for the associations between preterm birth and hence small birth size, with later-life disease, namely accelerated postnatal growth, resulting in increased total and subcutaneous adiposity, and illness severity, resulting in altered AT partitioning. It will now be important to establish whether infants born extremely preterm manifest an altered metabolic profile and are at risk of later overt disease. Therapeutic targets might prove to be the attenuation of the endogenous glucocorticoid response to neonatal intensive care and the restriction of rapid somatic and linear growth.
